These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8250991)

  • 41. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan.
    Kuno K; Okada Y; Kawashima H; Nakamura H; Miyasaka M; Ohno H; Matsushima K
    FEBS Lett; 2000 Aug; 478(3):241-5. PubMed ID: 10930576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro.
    Andrews HJ; Plumpton TA; Harper GP; Cawston TE
    Agents Actions; 1992 Sep; 37(1-2):147-54. PubMed ID: 1456176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage.
    Flannery CR; Little CB; Hughes CE; Curtis CL; Caterson B; Jones SA
    Matrix Biol; 2000 Nov; 19(6):549-53. PubMed ID: 11068209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of retinoic acid on proteoglycan turnover in bovine articular cartilage cultures.
    Campbell MA; Handley CJ
    Arch Biochem Biophys; 1987 Oct; 258(1):143-55. PubMed ID: 3662538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
    Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
    J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cartilage chondrolysis by fibronectin fragments causes cleavage of aggrecan at the same site as found in osteoarthritic cartilage.
    Homandberg GA; Davis G; Maniglia C; Shrikhande A
    Osteoarthritis Cartilage; 1997 Nov; 5(6):450-3. PubMed ID: 9536293
    [No Abstract]   [Full Text] [Related]  

  • 47. Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine.
    Badger AM; Cook MN; Swift BA; Newman-Tarr TM; Gowen M; Lark M
    J Pharmacol Exp Ther; 1999 Aug; 290(2):587-93. PubMed ID: 10411566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of interleukin 1-mediated proteoglycan degradation in bovine articular cartilage explants by addition of sodium hyaluronate.
    Morris EA; Wilcon S; Treadwell BV
    Am J Vet Res; 1992 Nov; 53(11):1977-82. PubMed ID: 1466488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay.
    Buttle DJ; Fowles A; Ilic MZ; Handley CJ
    Mol Pathol; 1997 Jun; 50(3):153-9. PubMed ID: 9292151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).
    Stracke JO; Fosang AJ; Last K; Mercuri FA; Pendás AM; Llano E; Perris R; Di Cesare PE; Murphy G; Knäuper V
    FEBS Lett; 2000 Jul; 478(1-2):52-6. PubMed ID: 10922468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
    Milner JM; Elliott SF; Cawston TE
    Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteoglycan depletion of intact articular cartilage by retinoic acid is irreversible and involves loss of hyaluronate.
    Von den Hoff HW; van Kampen GP; van der Korst JK
    Osteoarthritis Cartilage; 1993 Jul; 1(3):157-66. PubMed ID: 15449421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of naproxen and interleukin-1 on proteoglycan catabolism and on neutral metalloproteinase activity in normal articular cartilage in vitro.
    Glazer PA; Rosenwasser MP; Ratcliffe A
    J Clin Pharmacol; 1993 Feb; 33(2):109-14. PubMed ID: 8440758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measurement of aggrecanase-generated interglobular domain catabolites in the medium and extracts of cartilage explants using Western blot analysis.
    Hughes CE; Little CB; Caterson B
    Methods Mol Biol; 2003; 225():89-98. PubMed ID: 12769477
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of the hydroxamic acid derivate Ro 31-4724 on the metabolism and morphology of interleukin-1-treated cartilage explants.
    Steinmeyer J; Daufeldt S; Kalbhen DA
    Pharmacology; 1997 Aug; 55(2):95-108. PubMed ID: 9323309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of interleukin-1 and insulin like growth factor-1 on the release of proteoglycan components and hyaluronan from pig articular cartilage in explant culture.
    Fosang AJ; Tyler JA; Hardingham TE
    Matrix; 1991 Feb; 11(1):17-24. PubMed ID: 2027327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of an antibody against the matrix metalloproteinase-generated aggrecan neoepitope FVDIPEN-COOH to assess the effects of stromelysin in a rabbit model of cartilage degradation.
    Bayne EK; MacNaul KL; Donatelli SA; Christen A; Griffin PR; Hoerrner LA; Calaycay JR; Ayala JM; Chapman K; Hagmann W
    Arthritis Rheum; 1995 Oct; 38(10):1400-9. PubMed ID: 7575690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants.
    Yeh LA; Augustine AJ; Lee P; Riviere LR; Sheldon A
    J Rheumatol; 1995 Sep; 22(9):1740-6. PubMed ID: 8523355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Catabolism of aggrecan by explant cultures of human articular cartilage in the presence of retinoic acid.
    Ilic MZ; Mok MT; Williamson OD; Campbell MA; Hughes CE; Handley CJ
    Arch Biochem Biophys; 1995 Sep; 322(1):22-30. PubMed ID: 7574678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetics of release of aggrecan from explant cultures of bovine cartilage from different sources and from animals of different ages.
    Ilic MZ; Haynes SR; Winter GM; Handley CJ
    Acta Orthop Scand Suppl; 1995 Oct; 266():33-7. PubMed ID: 8553858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.